BioCentury
ARTICLE | Finance

SK becomes Korea’s third-largest public healthcare company after $800M IPO

July 2, 2020 11:06 PM UTC

Neurology company SK more than doubled its value to $8 billion on its first day of trading Thursday after raising just under $800 million in the largest biotech IPO in Korea so far this year.

The company’s first day pop follows the trend of double-digit or greater gains for biotechs debuting on NASDAQ and in Shanghai in recent weeks (see “Gan & Lee Hits Ceiling in First Day on Shanghai”; “Akouos Outshines Peers Among NASDAQ IPO Trio”)...